Gastrografin use shortens surgery time and hospital stay

Use of gastrografin for adhesive small bowel obstruction has significantly improved clinical outcomes. A study analyzed over 20,000 patients, revealing a reduction in time to the operating room, from an average of 2.63 days pre-gastrografin to 2.33 days post-gastrografin. Additionally, hospital length of stay decreased from 10.51 days to 6.09 days. Notably, the number of surgeries dropped by 44.7%, indicating enhanced efficiency in treatment following the adoption of gastrografin.